Category

Countries

Ampacet ProVitalTM+ Gamma-Protect Ensures Polypropylene Medical Plastics in Sterilization
Ampacet ProVitalTM+ Gamma-Protect Ensures Polypropylene Medical Plastics in Sterilization

Ampacet ProVitalTM+ Gamma-Protect Ensures Polypropylene Medical Plastics in Sterilization

  • 28-Sep-2023 2:39 PM
  • Journalist: Nina Jiang

Ampacet, a renowned leader in the global masterbatch industry, has recently introduced a groundbreaking medical-grade additive known as ProVital+ Gamma-Protect. This innovative additive is specifically engineered to safeguard the essential mechanical and optical properties of polypropylene-based medical and pharmaceutical products when subjected to gamma and e-beam sterilization processes.

In the realm of medical technology, gamma and e-beam sterilization techniques are widely employed to eradicate microorganisms such as bacteria, viruses, and spores from an array of critical components. These techniques are essential for ensuring the safety and efficacy of medical devices, in-vitro diagnostic equipment, and various packaging systems. However, it is a well-known challenge that gamma and e-beam sterilization can have a significant impact on the optical and mechanical attributes of polymers, leading to alterations in properties such as elongation, tensile strength, and impact resistance.

Ampacet's ProVital+ Gamma-Protect emerges as a highly efficient and purpose-built medical-grade solution to address these critical concerns. It plays a pivotal role in stabilizing polypropylene materials when subjected to the rigors of gamma or e-beam sterilization, thereby preserving the vital mechanical and optical characteristics of the polymer. This preservation is paramount for maintaining the performance and quality of polypropylene-based components used in crucial medical applications. The applications of this innovative solution encompass a broad spectrum, spanning from medical devices and in-vitro diagnostic equipment to pharmaceutical packaging systems.

One noteworthy achievement is that Ampacet's ProVital+ Gamma-Protect has undergone successful pre-evaluation for biocompatibility in accordance with ISO 10993, covering key aspects such as cytotoxicity, sensitization, and irritation. This rigorous evaluation further underscores its suitability for use in the demanding field of medical and pharmaceutical materials, providing a high level of confidence in its performance and safety.

In addition to its exceptional performance, Ampacet has implemented a stringent quality control framework for ProVital+ Gamma-Protect. This framework ensures consistency in formulation, encompassing a steadfast "no-change policy" for raw materials at both the CAS (Chemical Abstracts Service) and commercial levels. The manufacturing process adheres to consistent parameters, and cleanroom production practices are rigorously upheld to minimize the risk of cross-contamination. These measures collectively contribute to maintaining the highest standards of product quality and safety throughout the production chain.

Ampacet's ProVital+ Gamma-Protect represents a significant advancement in the field of medical-grade additives. Its ability to withstand the challenges posed by gamma and e-beam sterilization while preserving the critical properties of polypropylene-based materials is invaluable to the medical and pharmaceutical industries. With its commitment to biocompatibility and quality control, Ampacet ensures that this innovative additive meets the stringent requirements of these vital sectors, contributing to the safety and effectiveness of medical devices and pharmaceutical packaging systems.

Related News

A.P. Moller Holding Pours Investment into Fossil-Free Plastic Production in Antwerp
  • 01-Oct-2024 2:40 PM
  • Journalist: Sasha Fernandes
Uptick in the US Polypropylene Market Amid Stable Inventories and Reduced Hurricane Impact
  • 18-Sep-2024 2:44 PM
  • Journalist: Shiba Teramoto
European PP Market Witnesses Bearish Sentiments Midway Through September 2024
  • 20-Sep-2024 5:36 PM
  • Journalist: Emilia Jackson
Plastribution to Circulate DuCare Product in the UK and Ireland
  • 20-Sep-2024 12:09 PM
  • Journalist: Rene Swann